home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Laboratory Corp American Holdings (NY:LH)

260.40 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Laboratory Corp American Holdings

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Visualizing The Entire S&P 500 ↗

July 14, 2023

One of the biggest challenges market analysts have is how to visualize the companies that make up the S&P 500.

Via Talk Markets

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 03, 2023

Via Benzinga

Why Shares of Labcorp Dropped Monday ↗

July 03, 2023

The company completed the spinoff of contract research organization Fortrea Holdings.

Via The Motley Fool

Analyst Ratings for Laboratory Corp ↗

June 05, 2023

Via Benzinga

Labcorp's Q1 Revenue Falls On Decline In COVID-19 Testing Sales ↗

April 25, 2023

Via Benzinga

Earnings Outlook For Laboratory Corp ↗

April 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 03, 2023

Via Benzinga

Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster

July 03, 2023

From Fortrea Holdings Inc

Via GlobeNewswire

FDA Readies Proposal for Increased Oversight on Lab-developed Tests ↗

June 08, 2023

The FDA is preparing to increase regulation of a widely used class of tests conducted by laboratories to detect cancer, measure cholesterol, and identify other health issues. The FDA is developing a...

Via Benzinga

3 No-Brainer Stocks to Buy in a Correction ↗

May 26, 2023

Stock market downturns present great opportunities to go shopping for wonderful stocks.

Via The Motley Fool

Exact Sciences Serves Investors Exactly What They Wished For

May 15, 2023

Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The

Via MarketBeat

This Foreboding Sign Looms Over Laboratory Corp's Chart ↗

April 11, 2023

Via Benzinga

Why Is Enzo Biochem (ENZ) Stock Up 72% Today? ↗

March 17, 2023

Enzo Biochem (ENZ) stock is rocketing higher on Friday with heavy trading after the company agreed to an asset sale with Labcorp (LH).

Via InvestorPlace

3 Telemedicine Stocks to Watch as Healthcare Goes Digital ↗

April 28, 2023

The telemedicine stocks discussed in the article offer incredible upside ahead in the fast-evolving telehealth sector

Via InvestorPlace

7 Low-PE Ratio Blue-Chip Stocks Offering Both Quality and Value ↗

April 19, 2023

Make your dollars go as far as possible (and relatively safely) with these low-PE ratio blue-chip stocks to buy.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 17, 2023

The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning!

Via InvestorPlace

Why Enzo Biochem Stock Is Skyrocketing After Hours ↗

March 16, 2023

Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America

Via Benzinga

Where Laboratory Corp Stands With Analysts ↗

March 13, 2023

Via Benzinga

Earnings Scheduled For February 16, 2023 ↗

February 16, 2023

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...

Via Benzinga

Earnings Preview: Laboratory Corp ↗

February 15, 2023

Via Benzinga

Hopeful Golden Cross Forms On Laboratory Corp's Chart ↗

January 20, 2023

Via Benzinga

Ovia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking

February 22, 2023

From Labcorp

Via Business Wire

Labcorp Announces 2022 Fourth Quarter and Full-Year Results

February 16, 2023

From Labcorp

Via Business Wire

Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea

February 09, 2023

From Labcorp

Via Business Wire

Down 40% in 2022, Can Exact Sciences Recover in 2023? ↗

January 23, 2023

Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.

Via The Motley Fool

Labcorp to Announce Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023

January 18, 2023

From Labcorp

Via Business Wire

A Look Into Laboratory Corp's Debt ↗

January 18, 2023

Over the past three months, shares of Laboratory Corp Inc. (NYSE:LH) increased by 18.45%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at...

Via Benzinga

Labcorp Declares Quarterly Dividend

January 12, 2023

From Labcorp

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com